Eyebrain – neurological and psychiatric diseases

The founding purpose of EyeBrain is to provide medicine as well as clinical research with innovative tools for the functional exploration and analysis of healthy and diseased brain activity. Eyebrain’s mission is to propose an aid to the diagnosis of diseases that are difficult to detect and apprehend.

Eyebrain – neurological and psychiatric diseases

eyebrain

EyeBrain supports the fight of practitioners and patients against neurological and psychiatric diseases and learning disorders, with continual innovation as its essential driving force. The technology and services developed by this biotech company are the result of collaborations and strong partnerships with leading research laboratories in neuroscience and the best neurology and psychiatry clinical services, such as for example the Pitié-Salpêtrière Hospital in Paris.

The EyeBrain Trackers, EyeBrain T1 and EyeBrain T2, are medical devices that provide assistance in the diagnosis of neurological and psychiatric diseases. Based on oculomotricity, they provide early, objective and accurate markers of neurological diseases such as Parkinson’s syndrome or multiple sclerosis. They also help in the diagnosis of reading disorders. Unlike the eye-trackers dedicated to research, this system provides standardized oculomotor tests which are analyzed automatically to provide healthcare professionals comparison. The EyeBrain T1 allows eye movements to be recorded. It can be used with or without the helmet and its fixed chin strap ensures optimum reliability in signal recording. It is particularly suited to work in private practice in neurology, neuro-ophthalmology, ophthalmology, orthoptics as regards profitability and application. The new inovative EyeBrain T2 is the ideal tool for recording and analyzing eye and head movements as part of a clinical application. It is an innovative device for the early diagnosis of neurological, psychiatric and reading disorders.

Eyebrain is headquartered in France. Management Team is composed by Serge Kinkingnéhun, Magali Seassau, Maryline Zany and Richard Guillaume. The Scientific Council of EyeBrain consists of specialists renowned in the medical and scientific sectors, and allows the company to continuously validate consistency and relevance for the practitioner. EyeBrain is also involved in a continual quality process, which means it can certify its equipment as well as its services and processes to EC standards. The EyeBrain T1 and EyeBrain T2 are therefore class IIa medical devices, CE0459 certified.

More about Eyebrain : www.eyebrain.com

Eyebrain – neurological and psychiatric diseases – oculomotricity

Eyebrain – neurological and psychiatric diseases – oculomotricity